FDA NDC Directory · JSON-LD · Markdown

Harvoni

NDC 61958-1805 · HUMAN PRESCRIPTION DRUG · PELLET

Generic nameledipasvir and sofosbuvir
Labeler / ManufacturerGilead Sciences, Inc
Marketing categoryNew Drug Application (innovator) · App NDA212477
Dosage form / routePELLET · ORAL
Active ingredientsLEDIPASVIR (33.75 mg/1)
SOFOSBUVIR (150 mg/1)
Marketing started20190828
Package count1

External sources

Source: openFDA. Public-domain (CC0).